TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
Craig Hockenberry’s October 28, 2026, post recounts his lymphoma treatment, including chemotherapy, a pneumonia infection and substantial weakness. He says his strength and stamina began to return after his final infusions in May, and that a new sensation in his legs later suggested his spinal nerves might be recovering; the cause and longer-term outcome remain uncertain.
Craig Hockenberry, writing from a hospital bed in a personal post published October 28, 2026, described the effects of lymphoma treatment, including severe fatigue, major weight loss and a March bout of pneumonia, and said his strength began returning after his final chemotherapy infusions in May. He also reported a new sensation in the backs of his legs that he interpreted as a possible sign of nerve recovery, though he did not establish its cause or long-term significance.
Hockenberry said an initial six-week course of weekly lumbar punctures involved removing spinal fluid for analysis and replacing it with methotrexate. He described intense headaches afterward, which he said eased when he lay flat; those headaches subsided after the course ended at the end of January. He later received infusions of bendamustine and rituximab on a 28-day cycle.
He recounted changes to taste and appetite, fatigue, loss of muscle mass and a reported 50-pound weight loss over a couple of months. He said he did not experience nausea or hair loss, but his hair lost its usual body. Daily walks became part of his effort to stay active, although nerve damage affected his gait and balance.
In March, during the week after an infusion, Hockenberry said he developed pneumonia associated with a weakened immune system, his blood oxygen level fell below 90%, and his Apple Watch alerted him to an episode of atrial fibrillation. He said antibiotics helped the pneumonia resolve quickly. His doctor offered to skip the next chemotherapy cycle, but Hockenberry chose to continue. He completed his infusions in May and said his strength and stamina gradually improved.
Treatment Effects and Gradual Recovery
Hockenberry’s account gives readers a first-person description of how cancer treatment affected his daily life, from altered taste and reduced strength to a serious infection during treatment. He also describes the difficulty of managing pre-existing or treatment-period nerve symptoms while trying to remain active.
The post is a personal account, not a clinical report or guidance for other patients. Its details show that his experience included both complications and signs of improvement, but they cannot establish what other patients should expect or what caused his symptoms. People making decisions about cancer treatment or new symptoms should consult their own qualified medical professionals.
Popular right now
Shark PowerPro Reveal Plus Cordless Vacuum Cleaner, Charcoal, IZ376H
Ninja DualZone Smart XL Air Fryer, 10-Qt, 6-in-1, DZ950
Ninja Foodi Smart 6-in-1 Indoor Grill and Air Fryer, 4 Qt, FG551
As an affiliate, we earn on qualifying purchases.
From January Treatment to May
Hockenberry’s timeline begins with weekly lumbar punctures that continued for six weeks and ended in late January. He then describes chemotherapy infusions of bendamustine and rituximab on a 28-day schedule. He said the first week after an infusion was generally hardest, with improvement often beginning around the middle of the second week.
His post says nerve damage affecting his gait and balance had been present before the lymphoma was discovered. He remained concerned as tingling and numbness continued during treatment. After completing infusions in May, he reported a gradual return of appetite, strength and walking distance. The new sensation in his legs occurred during a walk around a local state park several weeks later.
“I’m writing this post from a hospital bed. And I couldn’t be happier.”
— Craig Hockenberry, in his October 28 post
Cause of Nerve Changes Unclear
Hockenberry said that, after finishing treatment, he felt an unfamiliar sensation in the backs of his legs when he bent his head forward during a walk. He wrote that the change over the following couple of weeks seemed to indicate his nerves were repairing themselves, but described that explanation as a guess. The account does not provide a confirmed medical cause, examination findings or a longer-term prognosis.
The post also does not specify why Hockenberry was in the hospital when he wrote, whether the atrial fibrillation episode recurred, or whether his lymphoma was in remission. His account does not state the cancer’s subtype or provide treatment-response results.
Recovery and Medical Follow-Up
Hockenberry’s post describes recovery as ongoing: he said his walking distance, strength and stamina increased after his final infusions, while nerve-related difficulties had been a concern during treatment. It does not announce a new treatment plan or give a date for a further medical update.
The next clear information would need to come from Hockenberry or his medical team, including any confirmed explanation for the nerve changes and updates on his lymphoma status. Until then, the improvement he describes remains a personal observation rather than a confirmed clinical conclusion.
Key Questions
Who shared the health update?
Craig Hockenberry published the personal account on Furbo.org on October 28, 2026. He wrote that he was in a hospital bed at the time, but did not state why he was hospitalized.
What treatment did Hockenberry describe?
He described a six-week course of weekly lumbar punctures involving methotrexate, followed by 28-day-cycle infusions of bendamustine and rituximab. He said his final infusions took place in May.
What complications did he report?
He described severe headaches after lumbar punctures, fatigue, muscle loss, altered taste, substantial weight loss and impaired balance. In March, he said he developed pneumonia while his immune system was weakened and received an Apple Watch alert for an atrial fibrillation episode.
Did Hockenberry confirm that his nerve damage was healing?
No. He reported a new sensation in the backs of his legs and said he believed it might indicate nerve recovery. He presented that explanation as a guess, not as a confirmed medical finding.
Did the post say whether his lymphoma is in remission?
No. The account describes treatment and recovery but does not provide a remission status, treatment-response results or a longer-term prognosis.
Source: furbo.org
